Employ Inc. Appoints Joey Humke as Chief Revenue Officer
September 23, 2024 07:00 ET
|
Employ Inc.
Employ Inc. Appoints Joey Humke as Chief Revenue Officer
Kula debuts the first complete hiring platform with purpose-built AI for recruiting
September 19, 2024 10:00 ET
|
Kula
San Francisco, California, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The rise of AI has transformed the recruiting playbook. At least 62 percent of recruiters expressed optimism about AI’s impact on...
Employ Inc. Opens Center of Excellence in Denver
September 18, 2024 07:00 ET
|
Employ Inc.
Employ Inc. Opens Center of Excellence in Denver
Pico Partners with Blue Ocean Technologies for After-Hours US Equities Trading Expanding PicoNet’s Capabilities
July 09, 2024 07:00 ET
|
Pico
Pico clients gain direct access to Blue Ocean Technologies ATS, unlocking expanded capabilities for US equities trading for after-hours trading.
Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the ATS Annual Meeting
May 22, 2024 11:20 ET
|
Kymera Therapeutics, Inc.
KT-621, a potent, selective, oral STAT6 degrader, demonstrated comparable or superior activity to dupilumab in preclinical studies including an asthma model shared at the ATS Annual Meeting ...
Upstream Bio Presents Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society International Conference
May 22, 2024 11:15 ET
|
Upstream Bio, Inc.
Positive results from a Phase 1 dose ranging study of verekitug (UPB-101) in asthma presented at ATS 2024
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
May 21, 2024 14:30 ET
|
InflaRx N.V.
JENA, Germany, May 21, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data...
Upstream Bio to Present Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society (ATS) International Conference
May 15, 2024 07:00 ET
|
Upstream Bio, Inc.
Upstream Bio will present clinical data from dose-ranging study of verekitug (UPB-101) in adults with asthma at the American Thoracic Society conference
Employ Welcomes New Chief Customer Officer
May 14, 2024 07:00 ET
|
Employ Inc.
Employ Welcomes Amanda Berger as New Chief Customer Officer
ClearStar Announces Appointment of Pam Dunsky as Chief Operating Officer
February 28, 2024 10:47 ET
|
ClearStar
ClearStar appoints Pam Dunsky as Chief Operating Officer (COO) to oversee Client Service and Operations.